A recent article in the Journal of Clinical Oncology, together with an associated editorial, have addressed the issue of whether evidence is now sufficient to argue that all men with prostate cancer should be treated with a statin. The article by Larsen et al. provides an analysis, based on data in the Danish health data […]![]()
